DALLAS, Oct. 31, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PRESS RELEASE -- Kali-Extracts, Inc. (USOTC: KALY) has announced taking a next step with the investor that has recently valued KALY's biopharmaceutical technology at $50 million. The valuation has been presented to KALY by an investor interested in acquiring KALY's U.S. Patented Cannabis Extraction Process and associated biopharmaceutical research and developments. KALY management has asked the investor to provide a "working" term-shee...
Browse Article Categories
Four Products Added to Colorado's List of Pesticides That Can Be Used on Cannabis
Rate this article
No Comments Yet
Be the first to share what you think!